APR January/February 2022 - 77

« INSTRUMENTATION
Selecting the appropriate platform and technology for a particular
application is also an important part of the assay development process.
References
1.
2.
3.
4.
5.
10.
Chemistry, manufacturing, and control (CMC) information for human gene therapy
investigational new drug applications (INDs). FDA Guidance Documents. https://www.fda.
gov/regulatory-information/search-fda-guidance-documents/chemistry-manufacturingand-control-cmc-information-human-gene-therapy-investigational-new-drug.
Accessed
December 20, 2021.
11.
Tajadini M, Panjehpour M, Javanmard SH. Comparison of SYBR Green and TaqMan methods
in quantitative real-time polymerase chain reaction analysis of four adenosine receptor
subtypes. Adv Biomed Res. 2014; 3:85. doi: 10.4103/2277-9175.127998.
Navarro E, Serrano-Heras G, Castaño MJ, Solera J. Real-time PCR detection chemistry. Clin
Chim Acta. 2015;439:231-50. doi: 10.1016/j.cca.2014.10.017.
Dobnik D, Kogovsek P, Jakomin T, et al. Accurate quantification and characterization
of adeno-associated viral vectors. Front Microbiol. 2019;10:1570. doi: 10.3389/
fmicb.2019.01570.
Clarner P, Lau SK, Chowdhury T, et al. Development of a one-step RT-ddPCR method
to determine the expression and potency of AAV vectors. Mol Ther Methods Clin Dev.
2021;23:68-77. doi: 10.1016/j.omtm.2021.05.003.
Lock M, Alvira MR, Chen S, Wilson JM. Absolute determination of single-stranded and selfcomplementary
adeno-associated viral vector genome titers by droplet digital PCR. Hum
Gene Ther Methods. 2014;25(2):115-125. doi: 10.1089/hgtb.2013.131.
6. Wang Y, Menon N, Shen S, Feschenko M, Bergelson S. A qPCR method for AAV genome titer
with ddPCR-level of accuracy and precision. Mol Ther Methods Clin Dev. 2020;19:341-346.
doi: 10.1016/j.omtm.2020.09.017.
7.
8.
9.
Lock M, McGorray S, Auricchio A, et al. Characterization of a recombinant adeno-associated
virus type 2 reference standard material. Hum Gene Ther. 2010;21(10):1273-1285. doi:
10.1089/hum.2009.223.
Zhen Z, Espinoza Y, Bleu T, Sommer JM, Wright JF. Infectious Titer Assay for AdenoAssociated
Virus Vectors with Sensitivity Sufficient to Detect Single Infectious Events.
Human Gene Therapy. 2004;15(7):709-715. doi: 10.1089/1043034041361262.
Marcial-Quino J, Gomez-Manzo S, Fierro F, et al. Stem-loop RT-qPCR as an efficient tool
for the detection and quantification of small RNAs in Giardia lamblia. Genes (Basel).
2016;7(12):131. doi: 10.3390/genes7120131.
Furuta-Hanawa B, Yamaguchi T, Uchida E. Two-dimensional droplet digital PCR as a tool
for titration and integrity evaluation of recombinant adeno-associated viral vectors. Hum
Gene Ther Methods. 2019;30(4):127-136. doi: 10.1089/hgtb.2019.031.
12. De BP, Chen A, Salami CO, et al. In vivo potency assay for adeno-associated virus-based gene
therapy vectors using AAVrh.10 as an example. Hum Gene Ther Methods. 2018;29(3):146155.
doi: 10.1089/hgtb.2017.246.
Author Biographies
Pete Clarner, Scientist I, GTxAU, holds a B.S. in Biology from Boston
College and a PSM in Biotechnology from Northeastern University. He
joined Biogen in 2012 as a member of the Bioassay and Gene Therapy
group of the Analytical Development department. In 2019 he joined the
Gene Therapy Accelerator Unit (GTxAU) within R&D. Pete has extensive
experience in AAV characterization and serves as the GTxAU SME,
particularly in PCR-based methods development, with emphasis on the
ddPCR platform.
Katelyn M. Mansfield, Scientist II, Technical Development, is a Scientist
at Biogen. She received her PhD in Cell and Molecular Biology from Boston
University and has been with the Analytical Development Department at
Biogen since 2019. Kate specializes in the development of cell-based assays
for Biogen's biologics portfolio, including AAV gene therapies.
www.americanpharmaceuticalreview.com |
| 77
»

https://www.fda.gov/regulatory-information/search-fda-guidance-documents/chemistry-manufacturing-and-control-cmc-information-human-gene-therapy-investigational-new-drug http://www.americanpharmaceuticalreview.com

APR January/February 2022

Table of Contents for the Digital Edition of APR January/February 2022